This page shows the latest Proteostasis news and features for those working in and with pharma, biotech and healthcare.
Meanwhile, Biogen licensed rights to a tau-targeting compound in development at Eisai for Alzheimer's in March, while Astellas signed a $1.2bn agreement with Proteostasis Therapeutics last November that
Astellas has teamed up with US company Proteostasis Therapeutics to investigate new ways of treating diseases caused by protein defects, an emerging field of pharmaceutical research. ... Astellas will work with Proteostasis initially on one undisclosed
The two organisations also announced in May, 2011, they would be stepping up their efforts into neurodegenerative disease, including biomarker research into neuroinflammation, neurovascular/mitochondria and proteostasis.
Licence. 83. Proteostasis/Elan. Discovery of disease-modifying small molecules for the treatment of neurodegenerative disorders.
The new phase will see the Eisai and UCL engage in joint research in neurodegenerative disease including biomarker research into neuroinflammation, neurovascular/mitochondria and proteostasis.
There will also be an opportunity for Proteostasis to receive an additional $30m in collaboration funding over the next five years. ... Elan will become a 24 per cent shareholder in Proteostasis and will have the right of first negotiation to license
More from news
Approximately 1 fully matching, plus 5 partially matching documents found.
Company divestment. 1, 530. Proteostasis Therapeutics / Astellas. Therapeutics modulating Unfolded Protein Response - multiple programmes.
More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.
Proteostasis Therapeutics strengthens leadership team. James DeTore, Geoffrey Gilmartin and Marija Zecevic join. ... Cambridge, Massachusetts-based Proteostasis Therapeutics has bolstered its leadership team with three new appointments.
More from appointments
Approximately 1 fully matching, plus 0 partially matching documents found.
Complete Medical delivers world-class solutions in medical communications, regulatory services, healthcare multichannel excellence, and strategic consultancy. We bring together specialist...